Search

Search Results
Results 4381 - 4390 of 4741 for multiple sclerosis
  • News - 12 Nov 2025
    One of humanity's most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic lupus erythematosus or, colloquially, lupus, Stanford Medicine investigators...
  • Drug - 4 Nov 2025
    Consumer Medicine Information (CMI) about Trazent intended for persons living in Australia.
  • News - 28 Oct 2025
    Neurodegenerative diseases (NDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), represent a growing global health...
  • White Paper - 26 Aug 2025
    Discover how transcription factors are revolutionizing drug discovery.
  • News - 17 Aug 2025
    Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a month — when they shop for next year's coverage.
  • Drug - 22 Jul 2025
    Consumer Medicine Information (CMI) about Solu-Medrol intended for persons living in Australia.
  • Drug - 2 Jul 2025
    Consumer Medicine Information (CMI) about Filosir intended for persons living in Australia.
  • Drug - 26 Jun 2025
    Consumer Medicine Information (CMI) about Gilenya intended for persons living in Australia.
  • Drug - 13 Jun 2025
    Consumer Medicine Information (CMI) about Mavenclad intended for persons living in Australia.
  • News - 6 Jun 2025
    This review highlights how air pollution and occupational inhalation exposures may contribute to neurodegenerative disorders by triggering epigenetic changes. The authors stress the urgent need for...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.